CombiGene AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-44.88	-35.67	-6.16	20.96	-29.38	Upgrade
Depreciation & Amortization	5.79	2.62	0.3	0.3	0.2	Upgrade
Asset Writedown & Restructuring Costs	10.9	-	2.29	2.29	2.29	Upgrade
Other Operating Activities	-2.34	-1.21	-11.7	-	-0.17	Upgrade
Change in Accounts Receivable	0.43	5.64	0.44	-1	-2.76	Upgrade
Change in Other Net Operating Assets	0.14	-1.94	-1.84	-0.45	-8.53	Upgrade
Operating Cash Flow	-29.95	-30.56	-16.67	22.11	-38.35	Upgrade
Capital Expenditures	-	-0.88	-	-	-	Upgrade
Cash Acquisitions	-	-	-	-	-3.11	Upgrade
Sale (Purchase) of Intangibles	-	-0.11	-	-0.15	-0.1	Upgrade
Investment in Securities	-	-0	-	-	-	Upgrade
Other Investing Activities	-0.08	-	-	-	-	Upgrade
Investing Cash Flow	-0.08	-0.99	-	-0.15	-3.21	Upgrade
Short-Term Debt Repaid	-	-	-	-	-7	Upgrade
Total Debt Repaid	-	-	-	-	-7	Upgrade
Net Debt Issued (Repaid)	-	-	-	-	-7	Upgrade
Issuance of Common Stock	-	-	-	65.88	82.29	Upgrade
Financing Cash Flow	-	-	-	65.88	75.29	Upgrade
Foreign Exchange Rate Adjustments	2.34	1.21	11.7	-	-	Upgrade
Net Cash Flow	-27.69	-30.34	-4.97	87.85	33.73	Upgrade
Free Cash Flow	-29.95	-31.44	-16.67	22.11	-38.35	Upgrade
Free Cash Flow Margin	-1498.07%	-448.59%	-58.00%	24.26%	-354.15%	Upgrade
Free Cash Flow Per Share	-1.51	-1.59	-0.84	1.28	-4.29	Upgrade
Cash Interest Paid	-	0	0	-	1.39	Upgrade
Levered Free Cash Flow	-17.33	-18.8	-11.83	13.01	-28.98	Upgrade
Unlevered Free Cash Flow	-17.33	-18.79	-11.83	13.01	-28.11	Upgrade
Change in Net Working Capital	-0.57	-3.7	1.4	1.44	11.29	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.